Researchers are simultaneously shrinking mass specs and broadening their tandem capabilities

Mini mass spec can detect lower opioid levels than other methods

Luke Lavis’s lab teaches old dyes new tricks at the HHMI campus

Adding enzyme to engineered yeast boosts production of thebaine, a key morphine intermediate

The first goal is to thwart the outbreak, but researchers also hope for new insights into combating the virus

A new report from the Cancer Research Institute highlights the U.S. and China as cell therapy leaders

With so many ingredients on hand, can the oncology community figure out how to sensibly and efficiently combine checkpoint inhibitors with other drugs?

New investor takes on a company trying to combine a range of pharmaceutical services

Surprised by proposal, scientific experts to ask agency chief to wait for their feedback before finalizing rule

Added surface glycine residues cause partial unfolding that adapts enyzyme to low temperatures

Researchers experiment with area-selective atomic layer deposition to precisely place layers of conducting and insulating materials within circuits

Combining vibrational circular dichroism and infrared spectroscopy yields real-time probe of asymmetric catalytic reactions

New investor takes on a company trying to combine a range of pharmaceutical services

Surprised by proposal, scientific experts to ask agency chief to wait for their feedback before finalizing rule

The startup is developing allosteric activators to increase levels of the vital metabolic molecule coenzyme A in pantothenate kinase-associated neurodegeneration

Chemical educator and Compound Interest blogger Andy Brunning wrings all the molecular details out of the popular goo

Headlines about plastic-eating organisms belie tough, competitive road to development

Flat, macrocyclic host captures fullerene guest with CH–π interactions

Simple pieces of equipment decrease the danger of moving small volumes of chemicals prone to igniting

A new National Academies report names and classifies the kinds of biological weapons that could emerge from techniques like CRISPR gene editing and DNA synthesis

Listen to the latest Stereo Chemistry episode that explores why certain drug targets are so vexing, and the cutting edge approaches chemists are taking to finally crack them

Method is possible replacement for phosphoramidite-based DNA synthesis

The early peek at data from a Phase I/II study excited families, physicians, and investors 

French pharmaceutical services firm is latest to move into the U.S.

Separating crystal nucleation and growth processes is key to controlling crystal dimensions

Molecular logic gates allow personal glucose meters to respond to many other targets

These exotic materials could find applications in electronics, catalysis, and quantum computing

Simple pieces of equipment decrease the danger of moving small volumes of chemicals prone to igniting

Acasti picks CordenPharma to extract omega-3s from krill

Piramal sites on different continents have become involved in producing Theracos’s diabetes treatment

The drug company is partnering with Calibr to develop universal CAR T-cells directed to different tumors via antibody switches

Skyhawk will receive $60 million up front to develop drug candidates that target RNA in neurological diseases

As universities embrace rapid communications and international students, they are learning that the free exchange of ideas comes with risks

Multifunctional surfaces could control liquid and particle movement in microfluidics or pipes

The electroactive material’s makers say it can kill antibiotic-resistant bacteria and battle body odor

News reports linking the gene-editing technology to cancer are the latest in a series of hyped alarms due to be tested in humans soon

On its 15th anniversary, ACS outreach program expands to a weeklong celebration

The drug company is partnering with Calibr to develop universal CAR T cells directed to different tumors via antibody switches